2024# AQI71  Ambulatory Glucose Management 

Measure Description:

Percentage of diabetic patients, aged 18 years and older, who receive an office-based or ambulatory surgery whose blood glucose level is appropriately managed throughout the perioperative period.The measure consists of four performance rates:a. Percentage of patients, aged 18 years and older, with a current diagnosis of diabetes mellitus receiving anesthesia services for office-based or ambulatory surgery whose blood glucose level is tested prior to the start of anesthesiab. Percentage of patients, aged 18 years and older, with a current diagnosis of diabetes mellitus receiving anesthesia services for office-based or ambulatory surgery who experienced a blood glucose level greater than or equal to 180 mg/dL (10.0 mmol/L) who received insulin prior to anesthesia end timec. Percentage of patients, aged 18 years and older, with a current diagnosis of diabetes mellitus receiving anesthesia services for office-based or ambulatory surgery who received insulin perioperatively and who received a follow-up blood glucose level check following the administration of insulin and prior to discharged. Percentage of patients, aged 18 years and older, with a current diagnosis of diabetes mellitus receiving anesthesia services for office-based or ambulatory surgery who experienced a blood glucose level greater than or equal to 180 mg/dL (10.0 mmol/L) who received education on managing their glucose in the postoperative period prior to discharge

Denominator: a. All patients, aged 18 years and older, with a current diagnosis of diabetes mellitus receiving anesthesia services for office-based or ambulatory surgery

Denominator definition: Office-based and ambulatory surgery is defined as a therapeutic or diagnostic procedure performed in a healthcare facility that does not require an overnight stay (less than 24 hours of care)

b. All patients, aged 18 years and older, with a current diagnosis of diabetes mellitus receiving anesthesia services for office-based or ambulatory surgery who experienced a blood glucose level greater than or equal to 180 mg/dL (10.0 mmol/L).

c. All patients, aged 18 years and older, with a current diagnosis of diabetes mellitus receiving anesthesia services for office-based or ambulatory surgery who received insulin perioperatively.

d. Percentage of patients, aged 18 years and older, with a current diagnosis of diabetes mellitus receiving anesthesia services for office-based or ambulatory surgery who experienced a blood glucose level greater than or equal to 180 mg/dL (10.0 mmol/L).

Numerator:

a. Patients who received a blood glucose test prior to the start of anesthesiab.

b. Patients who received insulin prior to anesthesia end timec.

c. Patients who received a follow-up blood glucose level check following the administration of insulin and prior to discharged.

d. Patients who received education on managing their glucose in the postoperative period prior to discharge

AQI71d Numerator Note: To meet this measure, the anesthesiologist or other member of the care team must provide both oral and written education. Provision of written materials alone is not sufficient.

Denominator Exceptions:

AQI71b: Documentation that insulin was not given because patient had severe comorbidities and glucose concentrations between 180 mg/dL and 250 mg/dL (10-13.9 mmol/L).